Tang Sunny X, Moore Tyler M, Calkins Monica E, Yi James J, Savitt Adam, Kohler Christian G, Souders Margaret C, Zackai Elaine H, McDonald-McGinn Donna M, Emanuel Beverly S, Gur Ruben C, Gur Raquel E
Department of Psychiatry, Philadelphia, Pennsylvania.
Department of Psychiatry, Philadelphia, Pennsylvania.
Biol Psychiatry. 2017 Jul 1;82(1):17-25. doi: 10.1016/j.biopsych.2016.08.034. Epub 2016 Sep 8.
Chromosome 22q11.2 deletion syndrome (22q11DS) is a promising model for studying psychosis risk. Direct comparisons of psychosis features between 22q11DS and nondeleted (ND) individuals are limited by inconsistency and small samples. In the largest study to date, we compare 22q11DS to ND in comorbidities, functioning, cognition, and psychosis features across the full range of overall severity.
ND youths (n = 150) ages 9 to 24 years were matched to 22q11DS individuals (n = 150) on age and sex, stratifying for presence of psychosis spectrum disorder. Individuals were evaluated for psychosis using the Structured Interview for Prodromal Syndromes, and for attention-deficit/hyperactivity, substance-related, and mood disorders. Differential item functioning analysis addressed whether 22q11DS differs from ND in the probability of clinically significant ratings while holding constant the overall level of psychosis.
Onset of psychosis proneness was similar among 22q11DS (mean: 11.0 years) and ND (mean: 12.1 years) individuals. Accounting for higher overall psychosis symptoms, 22q11DS participants were still more likely to manifest impaired stress tolerance, avolition, and ideational richness; ND individuals were more likely to exhibit unusual thoughts, persecutory ideas, and bizarre thinking. Cognition was impaired in 22q11DS, but it did not correlate with symptoms except ideational richness. Comorbid anxiety disorders were more likely in psychosis spectrum 22q11DS; substance-related disorders were more likely in ND. Global assessment of function was similar in 22q11DS and ND individuals, except among those with low total Structured Interview for Prodromal Syndromes scores.
Individuals with 22q11DS share overarching similarities with ND individuals in psychosis symptoms and age of onset for psychosis proneness; this continues to support the 22q11DS model as a valuable window into mechanisms contributing to psychosis.
22号染色体长臂11.2区缺失综合征(22q11DS)是研究精神病风险的一个有前景的模型。22q11DS个体与未缺失(ND)个体之间精神病特征的直接比较受到不一致性和小样本的限制。在迄今为止规模最大的研究中,我们在总体严重程度的全范围内,对22q11DS个体与ND个体在共病、功能、认知和精神病特征方面进行了比较。
将150名9至24岁的ND青年与150名22q11DS个体按年龄和性别进行匹配,并根据是否存在精神病谱系障碍进行分层。使用前驱综合征结构化访谈对个体进行精神病评估,并对注意力缺陷/多动障碍、物质相关障碍和情绪障碍进行评估。差异项目功能分析探讨了在保持精神病总体水平不变的情况下,22q11DS个体在临床上显著评分的概率是否与ND个体不同。
22q11DS个体(平均:11.0岁)和ND个体(平均:12.1岁)的精神病易发性发作年龄相似。考虑到总体精神病症状较高,22q11DS参与者仍更有可能表现出应激耐受性受损、意志缺失和思维丰富度受损;ND个体更有可能表现出异常思维、被害妄想和怪异思维。22q11DS个体的认知功能受损,但除思维丰富度外,与症状无相关性。精神病谱系22q11DS个体更易患共病焦虑症;ND个体更易患物质相关障碍。22q11DS个体和ND个体的总体功能评估相似,但前驱综合征结构化访谈总分较低的个体除外。
22q11DS个体与ND个体在精神病症状和精神病易发性发作年龄方面具有总体相似性;这继续支持22q11DS模型作为了解精神病发病机制的一个有价值的窗口。